Literature DB >> 3711305

Involvement of staphylococcal enterotoxins in nonmenstrual toxic shock syndrome.

B A Crass, M S Bergdoll.   

Abstract

Adequate evidence is available to show that the major toxin responsible for toxic shock syndrome (TSS) is TSS toxin 1 (TSST-1). More than 90% of the staphylococcal strains isolated from TSS patients produce this toxin. However, approximately 60% of these strains produce one or more of the staphylococcal enterotoxins, with a number of them producing only enterotoxin, primarily enterotoxin B. Of 55 staphylococcal strains isolated from nonmenstrual cases, 46 produced TSST-1; 42 produced one of the enterotoxins, including 8 that produced only enterotoxin B. The fact that the enterotoxins can produce in monkeys many signs and symptoms similar to those observed in TSS in humans implicates them as the cause of some cases of TSS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3711305      PMCID: PMC268810          DOI: 10.1128/jcm.23.6.1138-1139.1986

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Staphylococcal enterotoxin. I. Purification.

Authors:  M S BERGDOLL; H SUGIYAMA; G M DACK
Journal:  Arch Biochem Biophys       Date:  1959-11       Impact factor: 4.013

2.  Clinical manifestations of toxic shock syndrome.

Authors:  P J Chesney; J P Davis; W K Purdy; P J Wand; R W Chesney
Journal:  JAMA       Date:  1981-08-14       Impact factor: 56.272

3.  Toxic-shock syndrome not associated with menstruation. A review of 54 cases.

Authors:  A L Reingold; B B Dan; K N Shands; C V Broome
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

4.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

5.  Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome.

Authors:  P M Schlievert; K N Shands; B B Dan; G P Schmid; R D Nishimura
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

6.  An enterotoxin-like protein in Staphylococcus aureus strains from patients with toxic shock syndrome.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; A C Lee; P J Chesney; J P Davis; J M Vergeront; P J Wand
Journal:  Ann Intern Med       Date:  1982-06       Impact factor: 25.391

7.  Toxic shock syndrome caused by staphylococcal enterotoxin B. A report of 2 cases in children.

Authors:  L S Milner; J de Jager; P D Thomson; R O Doehring
Journal:  S Afr Med J       Date:  1983-05-21

8.  Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases.

Authors:  K N Shands; G P Schmid; B B Dan; D Blum; R J Guidotti; N T Hargrett; R L Anderson; D L Hill; C V Broome; J D Band; D W Fraser
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

9.  Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.

Authors:  P L Garbe; R J Arko; A L Reingold; L M Graves; P S Hayes; A W Hightower; F W Chandler; C V Broome
Journal:  JAMA       Date:  1985-05-03       Impact factor: 56.272

10.  Toxic-shock syndrome associated with phage-group-I Staphylococci.

Authors:  J Todd; M Fishaut; F Kapral; T Welch
Journal:  Lancet       Date:  1978-11-25       Impact factor: 79.321

  10 in total
  22 in total

1.  Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus.

Authors:  P D Fey; B Saïd-Salim; M E Rupp; S H Hinrichs; D J Boxrud; C C Davis; B N Kreiswirth; P M Schlievert
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

2.  Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains.

Authors:  F J Schmitz; C R MacKenzie; R Geisel; S Wagner; H Idel; J Verhoef; U Hadding; H P Heinz
Journal:  Eur J Epidemiol       Date:  1997-09       Impact factor: 8.082

3.  Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.

Authors:  J Valle; S Vadillo; S Piriz; E Gomez-Lucia
Journal:  Appl Environ Microbiol       Date:  1991-03       Impact factor: 4.792

4.  A DNA Spiegelmer to staphylococcal enterotoxin B.

Authors:  Werner G Purschke; Falko Radtke; Frank Kleinjung; Sven Klussmann
Journal:  Nucleic Acids Res       Date:  2003-06-15       Impact factor: 16.971

5.  Determination by western blot (immunoblot) of seroconversions to toxic shock syndrome (TSS) toxin 1 and enterotoxin A, B, or C during infection with TSS- and non-TSS-associated Staphylococcus aureus.

Authors:  J L Whiting; P M Rosten; A W Chow
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

6.  Biological and immunological properties of the carboxyl terminus of staphylococcal enterotoxin C1.

Authors:  G A Bohach; J P Handley; P M Schlievert
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

Review 7.  Toxic shock syndrome.

Authors:  J K Todd
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

8.  Nonproduction of toxic shock syndrome toxin 1 by coagulase-negative staphylococci.

Authors:  J Parsonnet; A E Harrison; S E Spencer; A Reading; K C Parsonnet; E H Kass
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

9.  Production of toxic shock syndrome-like illness in rabbits by Staphylococcus aureus D4508: association with enterotoxin A.

Authors:  B D McCollister; B N Kreiswirth; R P Novick; P M Schlievert
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

10.  Unexpected heterogeneity of multifunctional T cells in response to superantigen stimulation in humans.

Authors:  Monica A McArthur; Marcelo B Sztein
Journal:  Clin Immunol       Date:  2012-12-20       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.